fluorodeoxyglucose f18 has been researched along with Chronic Kidney Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kang, L; Su, T; Wang, H; Wang, S; Yang, L | 1 |
Hoogeveen, RM; Kaiser, Y; Kroon, J; Moens, SJB; Stroes, ESG; Verberne, HJ; Verweij, SL; Vogt, L | 1 |
Bhowmik, D; Brijwal, M; Damle, NA; Das, CJ; Kumari, K; Singh, G; Swamy, A | 1 |
Blake, GM; Compston, JE; Fogelman, I; Frost, ML; Goldsmith, D; Moore, AE; Siddique, M; Skingle, L | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Chronic Kidney Diseases
Article | Year |
---|---|
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Missed Diagnosis; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Renal Insufficiency, Chronic | 2020 |
3 other study(ies) available for fluorodeoxyglucose f18 and Chronic Kidney Diseases
Article | Year |
---|---|
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
Topics: Aged; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Renal Insufficiency, Chronic; Risk Factors | 2021 |
The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
Topics: Allografts; Biopsy; BK Virus; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Neoplasms; Kidney Transplantation; Middle Aged; Polyomavirus Infections; Positron Emission Tomography Computed Tomography; Renal Insufficiency, Chronic; Tumor Virus Infections | 2019 |
(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.
Topics: Adult; Aged; Bone Density; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteogenesis; Positron-Emission Tomography; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |